Royce & Associates LP cut its position in RTI Surgical, Inc. (NASDAQ:RTIX) by 9.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 648,155 shares of the medical equipment provider’s stock after selling 70,500 shares during the period. Royce & Associates LP owned approximately 1.12% of RTI Surgical worth $3,792,000 as of its most recent SEC filing.
A number of other institutional investors have also recently modified their holdings of RTIX. Teachers Advisors LLC grew its stake in shares of RTI Surgical by 32.4% in the fourth quarter. Teachers Advisors LLC now owns 153,071 shares of the medical equipment provider’s stock worth $497,000 after acquiring an additional 37,436 shares during the period. Russell Investments Group Ltd. grew its position in RTI Surgical by 176.0% during the first quarter. Russell Investments Group Ltd. now owns 78,055 shares of the medical equipment provider’s stock valued at $313,000 after buying an additional 49,777 shares during the period. Bank of New York Mellon Corp grew its position in RTI Surgical by 3.5% during the first quarter. Bank of New York Mellon Corp now owns 255,656 shares of the medical equipment provider’s stock valued at $1,022,000 after buying an additional 8,679 shares during the period. Ameriprise Financial Inc. grew its position in RTI Surgical by 29.5% during the first quarter. Ameriprise Financial Inc. now owns 44,807 shares of the medical equipment provider’s stock valued at $180,000 after buying an additional 10,215 shares during the period. Finally, TFS Capital LLC grew its position in RTI Surgical by 42.6% during the first quarter. TFS Capital LLC now owns 42,132 shares of the medical equipment provider’s stock valued at $169,000 after buying an additional 12,587 shares during the period. 69.99% of the stock is owned by institutional investors and hedge funds.
Several brokerages recently issued reports on RTIX. BidaskClub lowered shares of RTI Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, August 8th. ValuEngine upgraded shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd. Finally, Zacks Investment Research lowered shares of RTI Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, June 29th.
RTI Surgical, Inc. (NASDAQ RTIX) opened at 4.50 on Friday. RTI Surgical, Inc. has a 12-month low of $2.50 and a 12-month high of $6.00. The stock’s market cap is $265.65 million. The stock has a 50 day moving average of $4.83 and a 200 day moving average of $4.71.
RTI Surgical (NASDAQ:RTIX) last announced its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.02 EPS for the quarter, meeting the consensus estimate of $0.02. The business had revenue of $72.10 million for the quarter, compared to the consensus estimate of $70.25 million. RTI Surgical had a positive return on equity of 2.07% and a negative net margin of 6.53%. The firm’s revenue was up 6.7% on a year-over-year basis. On average, equities research analysts anticipate that RTI Surgical, Inc. will post $0.06 earnings per share for the current fiscal year.
In other RTI Surgical news, Director Nicholas J. Valeriani acquired 5,500 shares of the stock in a transaction on Monday, August 21st. The stock was purchased at an average price of $4.70 per share, for a total transaction of $25,850.00. Following the purchase, the director now directly owns 47,754 shares in the company, valued at $224,443.80. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP John N. Varela acquired 12,000 shares of the stock in a transaction on Friday, August 11th. The shares were acquired at an average price of $4.85 per share, with a total value of $58,200.00. Following the purchase, the executive vice president now owns 47,998 shares in the company, valued at $232,790.30. The disclosure for this purchase can be found here. Company insiders own 4.90% of the company’s stock.
WARNING: This piece of content was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://ledgergazette.com/2017/09/17/royce-associates-lp-sells-70500-shares-of-rti-surgical-inc-rtix.html.
About RTI Surgical
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.